MNI () Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 99

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

MNI () General Information

Description

Provider of neurological imaging and drug development services. The company is a neuroimaging services company specializing in the efficient application of scintigraphic biomarkers in drug development and clinical research for neurodegenerative and neuropsychiatric disorders.

Contact Information

Website
www.mnimaging.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 60 Temple Street 8A
  • New Haven, CT 06510
  • United States
Primary Industry
Monitoring Equipment
Other Industries
Drug Discovery
Acquirer
Invicro
Corporate Office
  • 60 Temple Street 8A
  • New Haven, CT 06510
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MNI () Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MNI ()‘s full profile, request access.

Request a free trial

MNI () Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

MNI () Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20070258887-A1 Antemortem method of diagnosing alzheimer's disease and quantitating extent or progression of amyloid deposits by in vivo imaging of brain Active 08-May-2006
US-7700616-B2 Antemortem method of diagnosing alzheimer's disease and quantitating extent or progression of amyloid deposits by in vivo imaging of brain Inactive 08-May-2006
EP-2023919-A2 Compounds and amyloid probes thereof for therapeutic and imaging uses Inactive 08-May-2006
EP-2023919-A4 Compounds and amyloid probes thereof for therapeutic and imaging uses Inactive 08-May-2006
US-20100143251-A1 Compounds and amyloid probes thereof for therapeutic and imaging uses Inactive 08-May-2006 A61K31/424
To view MNI ()’s complete patent history, request access »

MNI () Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MNI () FAQs

  • When was MNI () founded?

    MNI () was founded in 2000.

  • Where is MNI () headquartered?

    MNI () is headquartered in New Haven, CT.

  • What is the size of MNI ()?

    MNI () has 99 total employees.

  • What industry is MNI () in?

    MNI ()’s primary industry is Monitoring Equipment.

  • Is MNI () a private or public company?

    MNI () is a Private company.

  • What is MNI ()’s current revenue?

    The current revenue for MNI () is .

  • When was MNI () acquired?

    MNI () was acquired on 24-Feb-2016.

  • Who acquired MNI ()?

    MNI () was acquired by Invicro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process